The Lupus Accelerating Breakthroughs Consortium (Lupus ABC) is the first public-private partnership with the U.S. Food and Drug Administration (FDA) that focuses specifically on advancing the development of safer and more effective treatments urgently needed for people with lupus.
Lupus ABC is the first of its kind public-private partnership with the FDA, allowing researchers and patients to work together on lupus treatment breakthroughs.